Neurology CME

Credits: 0.50 CME
Penn State College of Medicine
Breaking Down the Barriers to Optimal Spinal Muscular Atrophy Care: Overcoming Diagnostic Delays, Facilitating Early Treatment, and Easing Caregiver Burden
Richard Finkel, MD
28 December, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin?
Barry Singer, MD
21 December, 2018
Credits: 1.00 CME
Medical Learning Institute, Inc.
Transforming Glioblastoma Management: A MasterClass on Evaluating Newer and Emerging Options in the Precision Medicine and Person-Centered Care Era
Steven Brem, MD
17 December, 2018
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Improving Long-Term Outcomes in Patients With Tardive Dyskinesia: Examining the Impact of New Therapeutic Options
Joseph McEvoy, MD
13 December, 2018
Credits: 1.25 CME
Medical Learning Institute, Inc.
Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?
Stewart Tepper, MD, FAHS
3 December, 2018
Credits: 1.00 CME
Penn State College of Medicine
Improving the Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention: How Is the Role of the Primary Care Clinician Evolving?
Deborah Friedman, MD, MPH
23 November, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease
Loren del Mar Pena, MD, PhD
8 November, 2018
Credits: 0.50 CME
Penn State College of Medicine
Assessing the Role of Recent Therapeutic Breakthroughs in the Treatment of Amyotrophic Lateral Sclerosis
Hiroshi Mitsumoto, MD, DSc
18 October, 2018
Credits: 1.50 MOC / CME / CE / CPE
Medical Learning Institute, Inc.
Navigating the Expanding Sphingosine-1-Phosphate Receptor Modulator Armamentarium for Multiple Sclerosis Management: Greater Opportunities for Patients With MS
Bruce Cree, MD, PhD, MAS
29 June, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Evolving Role of Current and Novel Therapies in Improving Outcomes in Adults With PKU
14 June, 2018
Credits: 1.00 CME / CE / CPE
University of Florida College of Medicine
Making the Connection: A Call to Action Against Undiagnosed Atrial Fibrillation—Improving Detection, Reducing Risk
Christian Ruff, MD, MPH
16 May, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Taking Stock of Recent Clinical Research in Generalized Myasthenia Gravis: What Is the Potential Impact of New Therapies on Disease Management?
Richard Barohn, MD
28 March, 2018
Credits: 0.50 CME
University of Cincinnati
Advances in Tardive Dyskinesia: A Patient's Journey From Diagnosis to Management and the Role of New Therapies for Improved Outcomes
Joseph McEvoy, MD
27 March, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Patient’s Journey From Diagnosis to Treatment: A Story on the Transformative Impact of Precision Medicine on Spinal Muscular Atrophy Management
Nancy Kuntz, MD
16 March, 2018
Credits: 0.50 CME
Penn State College of Medicine
Optimized Management of Lennox-Gastaut Syndrome: A Patient’s Journey From Initial Recognition to Treatment
Tracy Glauser, MD
15 March, 2018
Credits: 1.00 CME
Medical Learning Institute, Inc.
Navigating the Patient Journey From CIDP Diagnosis Through Initial Treatment and Onto Long-Term Maintenance Therapy
Todd Levine, MD
12 February, 2018
Credits: 0.75 CME
Medical Learning Institute, Inc.
Potential Clinical Implications of the Latest Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis: A Recap From Paris
Aaron Boster, MD
23 January, 2018